Malin Johannesson

887 total citations · 1 hit paper
16 papers, 595 citations indexed

About

Malin Johannesson is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Malin Johannesson has authored 16 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Physiology and 5 papers in Neurology. Recurrent topics in Malin Johannesson's work include Alzheimer's disease research and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Malin Johannesson is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Malin Johannesson collaborates with scholars based in Sweden, United Kingdom and United States. Malin Johannesson's co-authors include Lars Lannfelt, Christer Möller, Linda Söderberg, Patrik Nygren, Gunilla Osswald, Hanna Laudon, Fredrik Eriksson, Hans‐Erik Claesson, Linda Backman and Pontus Forsell and has published in prestigious journals such as Scientific Reports, Neurobiology of Disease and Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.

In The Last Decade

Malin Johannesson

15 papers receiving 575 citations

Hit Papers

Lecanemab, Aducanumab, and Gantenerumab — Binding Profile... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease
    2022 270 citations Linda Söderberg, Malin Johannesson et al. Neurotherapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malin Johannesson Sweden 11 350 165 138 135 108 16 595
Zhengwei Hu China 13 184 0.5× 320 1.9× 123 0.9× 79 0.6× 105 1.0× 37 642
Vasudevaraju Padmaraju India 9 252 0.7× 151 0.9× 69 0.5× 92 0.7× 68 0.6× 15 501
Alice Cheng United States 11 279 0.8× 304 1.8× 110 0.8× 90 0.7× 90 0.8× 14 700
Nicha Puangmalai United States 14 448 1.3× 353 2.1× 106 0.8× 82 0.6× 152 1.4× 24 773
Xiaohong Zuo China 10 375 1.1× 199 1.2× 147 1.1× 125 0.9× 190 1.8× 15 770
Ashley N. Nilson United States 3 616 1.8× 325 2.0× 62 0.4× 145 1.1× 111 1.0× 9 810
Geoffrey Pires United States 10 458 1.3× 393 2.4× 64 0.5× 87 0.6× 108 1.0× 18 731
Allal Boutajangout United States 6 374 1.1× 140 0.8× 53 0.4× 145 1.1× 105 1.0× 9 468
Marta Rodrı́guez Spain 8 408 1.2× 249 1.5× 48 0.3× 143 1.1× 174 1.6× 9 732
Paul Acton United States 8 605 1.7× 243 1.5× 39 0.3× 177 1.3× 147 1.4× 9 753

Countries citing papers authored by Malin Johannesson

Since Specialization
Citations

This map shows the geographic impact of Malin Johannesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malin Johannesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malin Johannesson more than expected).

Fields of papers citing papers by Malin Johannesson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malin Johannesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malin Johannesson. The network helps show where Malin Johannesson may publish in the future.

Co-authorship network of co-authors of Malin Johannesson

This figure shows the co-authorship network connecting the top 25 collaborators of Malin Johannesson. A scholar is included among the top collaborators of Malin Johannesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malin Johannesson. Malin Johannesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zachrisson, Olof, Malin Johannesson, Linda Söderberg, et al.. (2025). Exidavnemab binds to aggregated α-synuclein in human brains affected by α-synucleinopathies. Neurotherapeutics. 23(1). e00779–e00779.
2.
Nilsson, Jonna, Yiwen Jiang, Malin Johannesson, et al.. (2024). Plasma markers of neurodegeneration, latent cognitive abilities and physical activity in healthy aging. Scientific Reports. 14(1). 21702–21702. 1 indexed citations
3.
Johannesson, Malin, Linda Söderberg, Olof Zachrisson, et al.. (2024). Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains. Molecular and Cellular Neuroscience. 130. 103949–103949. 20 indexed citations
4.
Söderberg, Linda, Malin Johannesson, Eleni Gkanatsiou, et al.. (2024). Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities. Scientific Reports. 14(1). 10868–10868. 22 indexed citations
5.
Söderberg, Linda, Malin Johannesson, Patrik Nygren, et al.. (2022). Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease. Neurotherapeutics. 20(1). 195–206. 270 indexed citations breakdown →
6.
Gkanatsiou, Eleni, Charlotte Sahlin, Erik Portelius, et al.. (2021). Characterization of monomeric and soluble aggregated Aβ in Down’s syndrome and Alzheimer’s disease brains. Neuroscience Letters. 754. 135894–135894. 13 indexed citations
7.
Johannesson, Malin, Charlotte Sahlin, Linda Söderberg, et al.. (2021). Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease. Molecular and Cellular Neuroscience. 114. 103641–103641. 20 indexed citations
8.
Gkanatsiou, Eleni, Charlotte Sahlin, Erik Portelius, et al.. (2020). Characterization of monomeric and soluble aggregated Aβ in Down’s syndrome and Alzheimer’s disease brains. Alzheimer s & Dementia. 16(S2). 1 indexed citations
9.
Lannfelt, Lars, Linda Söderberg, Hanna Laudon, et al.. (2019). P4‐704: BAN2401 SHOWS STRONGER BINDING TO SOLUBLE AGGREGATED AMYLOID‐BETA SPECIES THAN ADUCANUMAB. Alzheimer s & Dementia. 15(7S_Part_31). 9 indexed citations
10.
Johannesson, Malin, Fredrik Eriksson, Werner Poewe, et al.. (2018). Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy. Frontiers in Neuroscience. 12. 452–452. 30 indexed citations
11.
Swanson, Chad J., Veronika Logovinsky, Linda Söderberg, et al.. (2017). [P2–055]: PHARMACOLOGICAL CHARACTERIZATION OF BAN2401‐MEDIATED Aβ PROTOFIBRIL CLEARANCE BY MICROGLIA. Alzheimer s & Dementia. 13(7S_Part_12). 1 indexed citations
12.
Lindström, Veronica, Therese Fagerqvist, Eva Nordström, et al.. (2014). Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice. Neurobiology of Disease. 69. 134–143. 106 indexed citations
13.
Forsell, Pontus, Åsa Brunnström, Malin Johannesson, & Hans‐Erik Claesson. (2012). Metabolism of Anandamide into Eoxamides by 15‐Lipoxygenase‐1 and Glutathione Transferases. Lipids. 47(8). 781–791. 18 indexed citations
14.
Johannesson, Malin, et al.. (2010). Development of a Fluorescent Intensity Assay Amenable for High-Throughput Screening for Determining 15-Lipoxygenase Activity. SLAS DISCOVERY. 15(6). 671–679. 10 indexed citations
15.
Johannesson, Malin, Linda Backman, Hans‐Erik Claesson, & Pontus Forsell. (2010). Cloning, purification and characterization of non-human primate 12/15-lipoxygenases. Prostaglandins Leukotrienes and Essential Fatty Acids. 82(2-3). 121–129. 22 indexed citations
16.
Gulliksson, M., Åsa Brunnström, Malin Johannesson, et al.. (2007). Expression of 15-lipoxygenase type-1 in human mast cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(9). 1156–1165. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengwei Hu Breakdown of academic impact, for papers by Vasudevaraju Padmaraju Breakdown of academic impact, for papers by Alice Cheng Breakdown of academic impact, for papers by Nicha Puangmalai Breakdown of academic impact, for papers by Xiaohong Zuo Breakdown of academic impact, for papers by Ashley N. Nilson Breakdown of academic impact, for papers by Geoffrey Pires Breakdown of academic impact, for papers by Allal Boutajangout Breakdown of academic impact, for papers by Marta Rodrı́guez Breakdown of academic impact, for papers by Paul Acton
Rankless by CCL
2026